Oropharynx Squamous Cell Carcinoma — Trials

Oropharynx Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: Aveta Biomics, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03381183	IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma	completed	Phase 1	19	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Dec 5, 2025	clinicaltrials
NCT04892875	A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers(PANTHEoN)	withdrawn	Phase 1	0	Jennifer ChoeOTHER	0